We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+1.9%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$559M
AUM Growth
-$480M
(-46%)
Cap. Flow
-$438M
Cap. Flow
% of AUM
-78.37%
Top 10 Holdings %
Top 10 Hldgs %
15.86%
Holding
756
New
216
Increased
66
Reduced
143
Closed
331
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALLK
Allakos
ALLK
|
+$25.1M |
| 2 |
Merck
MRK
|
+$9.57M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$9.37M |
| 4 |
BridgeBio Pharma
BBIO
|
+$9.02M |
| 5 |
Marvell Technology
MRVL
|
+$7.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$10.5M |
| 2 |
Citigroup
C
|
+$10.5M |
| 3 |
Microsoft
MSFT
|
+$9.87M |
| 4 |
OPTU
Optimum Communications Inc
OPTU
|
+$9.41M |
| 5 |
AES
AES
|
+$7.92M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.93% |
| 2 | Consumer Discretionary | 17.95% |
| 3 | Healthcare | 12.14% |
| 4 | Communication Services | 8.7% |
| 5 | Financials | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Sempra
SRE
$55.3B
| $671K | 0.12% |
+10,142
| New | +$643K |
|
|
FRC
227
DELISTED
First Republic Bank
FRC
| $662K | 0.12% |
3,205
+364
| +13% | +$76.8K |
|
228
Incyte
INCY
$24.3B
| $660K | 0.12% |
8,992
-21,706
| -71% | -$1.46M |
|
229
BioMarin Pharmaceuticals
BMRN
$11.7B
| $659K | 0.12% |
7,454
-36,506
| -83% | -$3.01M |
|
230
Freeport-McMoran
FCX
$97.1B
| $657K | 0.12% |
15,745
-34,361
| -69% | -$1.31M |
|
231
Toronto Dominion Bank
TD
$200B
| $653K | 0.12% |
+8,518
| New | +$621K |
|
|
PXD
232
DELISTED
Pioneer Natural Resource Co.
PXD
| $653K | 0.12% |
+3,593
| New | +$661K |
|
|
CIVI
233
DELISTED
Civitas Resources
CIVI
| $636K | 0.11% |
+12,989
| New | +$691K |
|
234
Equinor
EQNR
$90.6B
| $635K | 0.11% |
24,108
+5,807
| +32% | +$153K |
|
235
Darling Ingredients
DAR
$9.19B
| $629K | 0.11% |
+9,075
| New | +$659K |
|
|
MRO
236
DELISTED
Marathon Oil Corporation
MRO
| $628K | 0.11% |
38,257
-266,864
| -87% | -$4.29M |
|
237
PagSeguro Digital
PAGS
$2.63B
| $621K | 0.11% |
+23,694
| New | +$771K |
|
238
DXC Technology
DXC
$1.78B
| $620K | 0.11% |
+19,264
| New | +$628K |
|
239
Dollar Tree
DLTR
$24.7B
| $617K | 0.11% |
+4,391
| New | +$533K |
|
240
Huazhu Hotels Group
HTHT
$13B
| $611K | 0.11% |
16,375
-32,166
| -66% | -$1.41M |
|
241
Lennar Class A
LEN
$21.2B
| $610K | 0.11% |
5,426
+801
| +17% | +$81.9K |
|
242
Arthur J. Gallagher & Co
AJG
$64.3B
| $598K | 0.11% |
3,524
-31,176
| -90% | -$5.09M |
|
243
News Corp Class A
NWSA
$15.7B
| $592K | 0.11% |
26,532
-140,845
| -84% | -$3.22M |
|
244
Zebra Technologies
ZBRA
$17.5B
| $589K | 0.11% |
+989
| New | +$562K |
|
245
QuantumScape Corp
QS
$3.4B
| $587K | 0.11% |
+26,447
| New | +$724K |
|
246
Dick's Sporting Goods
DKS
$17.9B
| $584K | 0.1% |
5,080
-13,519
| -73% | -$1.62M |
|
247
Thermo Fisher Scientific
TMO
$214B
| $579K | 0.1% |
+868
| New | +$542K |
|
|
HES
248
DELISTED
Hess
HES
| $577K | 0.1% |
7,798
-23,214
| -75% | -$1.88M |
|
|
TTM
249
DELISTED
Tata Motors Limited
TTM
| $577K | 0.1% |
17,995
-27,630
| -61% | -$870K |
|
|
DISH
250
DELISTED
DISH Network Corp.
DISH
| $575K | 0.1% |
+17,724
| New | +$660K |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q4 2021 Portfolio in Review
As of Q4 2021, Seven Eight Capital held 756 positions worth $559M, down 46% from $1.04B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Seven Eight Capital withdrew a net $438M in Q4 2021, closing 331 positions and reducing 143 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $10.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Seven Eight Capital opened a new position in Allakos worth $3M.
- Seven Eight Capital's largest Q4 2021 buy was Allakos: 306,723 shares worth $3M.
- Seven Eight Capital added most to Mimecast Limited in Q4 2021, an estimated $6.07M increase.
- Seven Eight Capital's biggest Q4 2021 reduction was Fidelity National Information Services, cutting an estimated $7.12M.
- Seven Eight Capital fully exited Bristol-Myers Squibb in Q4 2021, selling an estimated $10.5M.
- Seven Eight Capital's ten largest holdings make up 16% of its $559M portfolio in Q4 2021.
- Seven Eight Capital opened 216 new positions and closed 331 in Q4 2021.
- Seven Eight Capital's portfolio value fell 46% quarter-over-quarter to $559M.
Based on Seven Eight Capital's 13F filing for Q4 2021, filed 14 Feb 2022.